Critical examination of approaches exploited to assess the effectiveness of transmission-blocking drugs for malaria brucei (IC of 0.6 μg/ml) and T. b. rhodesiense (IC of 0.5 μg/ml) with low cytotoxicity (CC of 30 μg/ml). Saussurea costus and Commiphora wightii, showed pronounced potency against T. cruzi with an IC of 3.6 and 2.5 μg/ml, respectively. Jatropha pelargonifolia and Solanum villosum exhibited pronounced activity toward L. infantum with an IC of 3.2 and 2.0 μg/ml, respectively. M. parviflora, S. costus, C. Maytenus parviflora showed the highest activity against T. b. brucei (IC 50 of 0.6 μg/ml) and T. b. rhodesiense (IC 50 of 0.5 μg/ml) with low cytotoxicity (CC 50 of 30 μg/ml). Saussurea costus and Commiphora wightii, showed pronounced potency against T. cruzi with an IC 50 of 3.6 and 2.5 μg/ml, respectively. Jatropha pelargonifolia and Solanum villosum exhibited pronounced activity toward L. infantum with an IC 50 of 3.2 and 2.0 μg/ml, respectively. M. parviflora, S. costus, C. wightii, J. pelargonifolia and S. villosum showed relevant selectivity.
In vitro activities of plant extracts from Saudi Arabia against malaria, leishmaniasis, sleeping sickness and Chagas disease Trypanosoma and Leishmania infections are a serious health problem worldwide. Mortality and morbidity due to these protozoa in Asia, Africa and Latin-America are worthy of attention. African trypanosomiasis is caused by Trypanosoma brucei rhodesiense and T. b. gambiense. T. b. rhodesiense is responsible for causing the disease in east and southern Africa [1, 2] . Sleeping sickness is a major cause of mortality and morbidity in sub-Saharan Africa and causes serious economic and health problems accounting for 1.5 million disability-adjusted life years, a scale representing the loss of healthy and productive life per year due to disease [3, 4] . 60million people are at risk of infection, which is fatal when left without treatment [5, 6] . This disease was classified as a category 1 by the Special Program for Research and Training in Tropical Diseases (TDR) of the WHO due to its high rate of re-emergence [4] . WHO report of 16 February 2018 , that continuous control efforts have reduced the new cases numbers. In 2009, the reported number dropped below 10,000 for the first time in the last 50 years. In 2012, WHO set a global elimination target to achieve 'fewer than 2000 reported cases per year' by 2020. In 2015, there were 2804 cases recorded. Nowadays there are only four drugs (pentamidine, suramin, eflornithine and melarsoprol) beside nifurtimox-eflornithine combination therapy for the second stage disease approved for treatment [7, 8] which requires long parenteral administration and causes frequent and sometimes severe side effects. It is also unaffordable for poor people in third world and developing countries. Additionally, eflornithine and pentamidine are not active against T. b. rhodesiense. Several patients develop drug resistance and fail to respond to melarsoprol [9] .
More than 28 million humans are at risk of infection by Chagas disease (American trypanosomiasis) caused by T. cruzi and 15 million are infected [10] . The disease is endemic in Latin American countries and transmitted to man via contact with Triatome bugs [11] . People infected with chagas disease manage their condition either with nifurtimox or benznidazole, however, not without severe side effects [10] .
Leishmaniasis is caused by several Leishmania species. Clinical symptoms of leishmaniasis are varying from ulcers in cutaneous leishmaniasis [12] to progressive nasopharyngal involvement in mucocutaneous leishmaniasis or disseminating visceral leishmaniasis (VL) [13, 14] . Leishmania donovani is particularly prevalent in India and Nepal while L. infantum cause infantile VL in the Mediterranean region and Latin America [14] . WHO reported that about 12 million people are infected all over the world [15, 16] . Antimonials, miltefosine and amphotericin B are drugs of choice. In several undeveloped countries in Africa, Asia and Latin America, treatment may still depend on traditional herbal products, of which the efficiency and safety are uncertain.
There is a need for re-examining several medicinal plants for the antiparasitic activity potential since natural products either from microorganisms or plants represent an unlimited source for novel drugs [13, 17] . In this study, we explored the in vitro antitrypanosomal and antileishmanial potency of 31 plant species in an attempt to identify possible new antitrypanosomal and antileishmanial 'hits'. The plants were randomly selected for in vitro evaluation adopting standard screening procedures [13, 18] . The random selection approach was based on our previous experience [19] [20] [21] .
Materials & methods

Chemicals
Benznidazole, suramin, miltefosine and tamoxifen were used as a reference drug control for T. cruzi, T. b. brucei and rhodesiense, L. infantum and MRC-5, respectively. The reference drugs were obtained from WHO-TDR and Sigma-Aldrich (Bornem, Belgium).
Plant material
Totally, 31 plants belonging to 23 families were collected from Arabian Peninsula (Saudi Arabia and Jordan) and Africa (Egypt, Libya and Sudan) between January and February 2014. Random collection of the plants was followed by in vitro antiparasitic screening following standard approaches [13] . Voucher samples are kept at the Pharmacognosy Department Herbarium, Faculty of Pharmacy, Cairo University. The collected plants were air-dried, then grounded.
Preparation of plant extracts
Dried powdered plant materials (40 g each) were separately extracted with methanol (4 × 100 ml) using homogenizer. The solvent free methanol extract (ME) was kept for further in vitro screening tests at 4
• C.
Fractionation of some selected crude extracts Six crude extracts were selected for further fractionation to verify the effect on the activity. Three active extracts (Pistacia atlantica, Saussurea costus and Solanum villosum) and three inactive ones (Vicia ervilia, Marrubium vulgare and Verbascum longibracteatum) were randomly selected. The ME of the selected plants were suspended in water and then fractionated by consecutive partitioning against methylene chloride (fr-A), and n-butanol (fr-B), in addition to fr-C representing the remaining aqueous [22] . All the prepared fractions were re-screened for their in vitro antiprotozoal activity.
In vitro biological assay
Standard protocols used by the Lab of Microbiology, Parasitology and Hygiene, Faculty of Pharmaceutical Sciences, Biomedical and Veterinary Sciences of the University of Antwerp, Belgium were applied [13] .
Test plate production
The tests were done in 96-well plates (Greiner, Bio-One, Wemmel, Belgium) [19] . Dilutions were done by a robotic station (BIOMEK 2000, Beckman, CA, USA). All experiments were carried out in duplicate in an independent replicate experiment.
Antitrypanosomal potency
Trypomastigotes of T. b. brucei (suramin-sensitive) Squib-427 strain were cultured in Hirumi-9 medium (at 37
• C and 5% CO 2 ) supplemented with 10% fetal calf serum following the procedures described in [23] [24] [25] . The T. b. rhodesiense assay was performed as described in [26] . Stock solutions of the extracts were prepared according to [27] . Upon the addition of trypomastigotes from an axenic culture to the microtiter plate containing the extract dilutions, it was incubated for 72 h in 5% CO 2 at 37
• C. Resazurin (12.5 mg resazurin in 100 ml distilled water) was then added to each well and further incubated for 2-4 h. The plate was then read in a Spectramax Gemini XS microplate fluorimeter (Molecular Devices Cooperation, CA, USA) using an emission λ 588 nm and excitation λ 536 nm [24] .
Trypanosoma cruzi Tulahuen CL2 (nifurtimox-sensitive) strain was maintained on MRC-5 cells and the antitrypanosomal potency on intracellular amastigotes was as described in [12, 25] procedures.
Antileishmanial activity
Mouse macrophages were stimulated by intraperitoneal injection of starch. Two days later, the macrophages were collected and seeded (3 × 10 4 ) in 96-well plates incubated in 5% CO 2 at 37 • C. After 2 days, ex vivo (spleenderived) amastigotes of L. infantum (MHOM/FR/96/LEM3323) were used to infect the primary peritoneal murine macrophages (PMM) at a 10:1 infection ratio. The plates were further incubated for 2 h before addition of the sample dilutions. Cells were dried after 5 days of incubation, fixed with methanol and stained with 20% Giemsa for microscopic reading. Results were expressed as percentage reduction of amastigote burden compared with the control untreated cultures.
The potency of the tested samples was assessed according to the mentioned SC. Score 1: inactive; 2: mild; 3: moderate; 4: pronounced; 5: strong; 6: very strong activity.
Cytotoxicity assay
MRC-5 cells (human embryonic lung fibroblasts) or PMM were cultivated in MEM medium or RPMI 1640 (Roswell Park Memorial Institute) medium, respectively, supplemented with L-glutamine (20 mM), 5% FCS and 16.5 mM NaHCO 3 (37 • C and 5% CO 2 ). Then, 10 4 cells/well were seeded onto the prediluted sample test plates, and then incubated at 5% CO 2 and 37
• C for 72 h. Cells viability was determined fluorimetrically after addition of resazurin.
Results
In a continuation of our interest in exploring plants with antiprotozoal potential [19] [20] [21] [28] [29] [30] Analysis of the results is based on IC 50 -values (μg/ml), a scoring system (SC) as adopted by Lab of Microbiology, Parasitology and Hygiene was used (Table 1) .
Only the extract of M. parviflora (aerial parts) showed SC 5 with an IC 50 of 0.5 μg/ml (SI 56.3) and 0.5 μg/ml (SI 64) against T. b. brucei and T. b. rhodesiense, respectively, which could represent a promising candidate. Most of the plant extracts had low cytotoxicity (SC 1 or 2), except four extracts showing moderate cytotoxicity (SC 3). The most sensitive protozoa was T. b. rhodesiense with eight extracts of SC 3, three with SC 4 and one with SC 5, whereas the most resistant one was L. infantum, with only four extracts with SC 3 and two with SC 4.
Cytotoxicity & selectivity Twenty-four samples were noncytotoxic against MCR5 cells (score 1, CC 50 >37) and eight samples had low cytotoxicity (SC 2, CC 50 >13 μg/ml) ( Table 1) . Only four extracts showed moderate cytotoxicity (SC 3, CC 50 >5 μg/ml), namely S. costus root, Combretum hartmannianum stem and bark, and aerial parts of Jatropha pelargonifolia with CC 50 of 6.9, 10.4, 10.5 and 12.9 μg/ml respectively. No further screening of these samples was undertaken with the exception of S. costus extract that was further fractionated since Julianti et al. [31] reported antitrypanosomal activity of sesquiterpene lactones of S. costus. The ME of M. parviflora aerial parts (SI 56.3), Schinus molle oil resin (SI 31.7) and Pistacia lentiscus root oil (SI 30.3) showed high selectivity toward T. b. brucei based on their cytotoxicity and IC 50 . The most selective extracts toward T. b. rhodesiense were M. parviflora aerial parts (SI 64.0) followed by P. atlantica leaves (SI 32.0), Commiphora myrrha gum resin (SI 28.0), and S. molle oleoresin (SI 22.7). In addition, the ME of C. wightii gum resin (SI 9.3), Solanum diphyllum root (SI 8.9) and P. atlantica leaves (SI 7.4) showed the highest selectivity against T. cruzi. S. villosum (SI 31.5) followed by P. atlantica (SI 7.4) were the most selective against L. infantum.
Antitrypanosomal activity
Among all tested plants extracts, the extract of M. parviflora aerial parts (family Celesteraceae) showed the most potent activity against T. b. rhodesiense (score 5) with an IC 50 of 0.5 μg/ml, SI 64 and low cytotoxicity score 2. It also exhibited strong activity (score 5) against T. b. brucei (IC 50 0.5 μg/ml) and moderate activity (score 3) against L. infantum (IC 50 >10.77 μg/ml) ( Table 1 ). On T. b. brucei, S. molle oleoresin, P. lentiscus root oil and Boswellia carterii gum resin exhibited pronounced activity (score 4) with an IC 50 of 2.0, 2.1, 2.8 μg/ml and SI 31.7, 30.3, 9.8, respectively. Both S. molle and P. lentiscus exhibited no cytotoxicity (score 1), whereas B. carterii showed low cytotoxicity (score 2). Five tested crude extracts showed moderate activity (score 3) with an IC 50 >3 μg/ml, whereas only two tested samples were of mild activity (score 2) with an IC 50 >9 μg/ml. Again M. parviflora aerial parts ME demonstrated strong activity (score 5) with an IC 50 of 0.5 μg/ml, SI 64.0 and low cytotoxicity score 2. The P. atlantica leaves ME, Commiphora myrrha gum resin and S. molle oil resin showed pronounced activity (score 4) with an IC 50 of 2.0, 2.2 and 2.8 μg/ml and SI 32.0, 28.0, 22.7, respectively. Eight crude extracts (22.22%) showed moderate activity (score 3) with an IC 50 >4 μg/ml, whereas five samples showed mild activity (score 2) with an IC 50 >11 μg/ml. The C. wightii gum resin demonstrated pronounced activity (score 4) with an IC 50 of 2.4 μg/ml, SI 9.3 with low cytotoxicity score 2 followed by S. costus root ME (IC 50 of 3.5, 2.4 μg/ml and SI 1.96) that exhibited moderate cytotoxicity score 3. Six crude extracts showed moderate activity (score 3) with an IC 50 >4 μg/ml, whereas eight crude extracts were of mild activity (score 2) with an IC 50 >11 μg/ml.
Antileishmanial activity
The ME of S. villosum and J. pelargonifolia aerial parts exhibited pronounced activity (score 4) against L. infantum (Table 1) , with an IC 50 of 2.03 and 3.17 μg/ml and SI of 31.55 and 4.08, respectively. S. villosum exerted a cytotoxic effect with IC 50 of 2.0 μg/ml (score 4) while J. pelargonifolia exhibited no cytotoxicity against PMM cell line. Four tested crude extracts showed moderate activity (score 3) with an IC 50 >4 μg/ml, whereas three tested crude extracts were of mild activity (score 2) with an IC 50 >11 μg/ml.
Effect of crude extracts fractionation
Random selection of three active and three inactive extracts was applied for further fractionation to verify the effect of fractionation on the activity. These plants were P. atlantica, S. costus, S. villosum, V. ervilia, M. vulgare and V. longibracteatum. Five of the selected plants were found to be of no or low cytotoxicity (score 1 or 2) and only S. costus was of a moderate cytotoxicity (SC 3).
Fractionation caused significant increase in the antiprotozoal activity of the aforementioned plants except for P. atlantica (Table 2) . Fr-B of S. villosam showed very strong activity (score 6) against L. infantum with an IC 50 of 0.5 μg/ml (however, accompanied by cytotoxicity on PMM with an IC 50 of 0.5 μg/ml). In addition, a pronounced activity (score 4) was recorded against T. b. rhodesiense with an IC 50 .0 μg/ml, respectively) was much higher than the activity of the crude ME with the same level of cytotoxicity (score 3). S. costus (fr-B) revealed high activity against tested protozoa (scores 3-5) higher than that of the total ME yet it exhibited higher cytotoxicity (score 5).
Upon fractionation of the inactive ME of V. ervilia seeds, it was noticed that fr-B and fr-A exhibited mildto-moderate antitrypanosomal activity (scores 2 and 3). In the same vein, fr-B of the inactive V. longibracteatum aerial parts ME showed mild-to-moderate activity (scores 2 and 3) against T. b. rhodesiense and L. infantum. Also, fractionation of the crude ME of M. vulgare against T.b. rhodesiense lead to increase in the potency from score 2 to score 3 (fr-A). On the other hand, our findings indicated that all P. atlantica fractions were inactive (score 1) against all tested protozoa while its total crude ME exhibited moderate (score 3) to pronounced (score 4) activity.
Discussion
The most promising activity was demonstrated by M. parviflora against T. b. brucei and T. b. rhodesiense. Nothing was found in the literature regarding the phytochemical constituents of M. parviflora, except the study conducted in the Kingdom of Saudi Arabia that reported the presence of flavonoid, phenol, saponin, alkaloid, triterpenoid and anthraquinone [32] . It was reported that several anthraquinone [33] and alkaloid derivatives [34, 35] possess antitrypanosomal and antileishmanial activity. It was found that some alkaloids intercalate DNA target the sensitive kDNA of the trypanosomes [34, 35] . The possible presence of anthraquinone and alkaloid content [32] (from results of phytochemical screening,unpublished data) of Maytenus parviflora may explain it spotent activity against T. b. brucei and T. b. rhodesiense.
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Future Med. Chem. (Epub ahead of print) future science group Table 2 . Antiprotozoal activity of subfractions obtained from randomly selected active and inactive extracts. In another study, M. senegalensis showed strong activity against Plasmodium falciparum [36] that encourage further study of the antiparasitic activity of this plant. It was noted that extracts of several plants under investigation, namely, S. molle, P. atlantica, C. wightii, B. carterii and Solanum diphyllum exhibited moderate to pronounced potency against both T. brucei and T. cruzi, which is in agreement with findings of [10] who reported that many natural agents which have been examined against T. brucei also affected T. cruzi. The results revealed that the most active plant against T. cruzi was C. wightii followed by S. costus. The most possible cause of their pronounced activity against T. cruzi is their content of quinonoid components [37] . It has been reported that quinonoids [38, 39] and sesquiterpene lactones [31] in both plants exhibit strong activity against T. cruzi.
The ME of J. pelargonifolia and S. villosum exhibited pronounced activity against L. infantum. Nothing was found in the literature regarding the chemical or biological investigation of J. pelargonifolia. In a review on the active constituents isolated from certain plants used traditionally for leishmaniasis treatment, two terpenes: jatrogrossidione isolated from J. grossidentata and jatrophone from J. isabellii, are among the potent molecules described [40, 41] . In another study, the in vivo, antileishmanial activity of jatrophone from J. isabelli was reported. This compound is active against the virulent strains of Leishmania, but reported to be toxic for clinical use [42] . Several diterpenes were isolated from the genus Jatropha showing antiplasmodial activity [43] [44] [45] . Further studies on J. pelargonifolia for the isolation of the active constituents and evaluation of in vivo efficacy and safety are highly recommended. The herein reported pronounced antileishmanial activity of S. villosum cultivated in Egypt is in accordance with findings of [19] who studied the same plant species collected from Saudi Arabia. Among Solanum species, S. arboreum Dunal demonstrated leishmanicidal activity [46] . Abdel-Hamid et al. [47] initiated a study for the isolation of the phytoconstituents of the n-butanol fraction of S. villosum, which gave positive test for saponin and alkaloid in preliminary screening. The study resulted in isolation of two furanostanol saponin glycosides, a known glycoside borivilianoside D, and a new glycoside (3β, 5α, 25R)- [47] . Thus, the potency of n-butanol fraction of S. villosum could be attributed to their content of steroidal glycosides [48] or steroidal alklaoids [49, 50] .
Our study revealed an additional four potent antileishmanial medicinal plants to be added to the traditionally used medicinal plants for Leishmania treatment worldwide. Most of the tested plant extracts were less active than the drugs used against L. infantum except for P. atlantica, C. wightii, M. parviflora and S. villosum. Their extracts showed antileishmanial activities with IC 50 of 8.6, 9.5, 10.7 and 2.0 that roughly compares to the standard drug miltefosine IC 50 (10.7 μg/ml). It is noteworthy to mention that the aforementioned plants are of no or low cytotoxicity. The crude extracts are composed of several different constituents, and the potent compounds might show higher potency in their less complex form. For example, the V. longibracteatum and S. villosum ME showed an antileishmanial activity with IC 50 of 32.46 and 2.03 μg/ml, respectively (Table 1) . On further fractionation, their n-butanol fractions showed activity against L. infantum with an IC 50 of 9.5 and 0.5 μg/ml (Table 2) , respectively, less than that of the reference drug miltefosine (IC 50 of 10.7 μg/ml), which may indicate a chance for isolation of more active constituents.
Saussurea costus (fr-B) showed strong activity against tested protozoa (SC 3-5), which is accompanied by high cytotoxicity (SC 5). Thus, fr-B of S. costus exhibits potent antiprotozoal activity but is strongly related to its high cytotoxicity.
The biologically active constituents of V. ervilia, M. vulgare and V. longibracteatum acting in their less complex fractionated form rather than acting collectively in the total crude ME. Further detailed study on the aforementioned plant species for isolation of their bioactive compounds is on track. The absence of activity of P. atlantica different tested fractions might be due to the synergestic effect of P. atlantica constituent in the total ME rather than acting fractionated.
Conclusion
In the present study, in vitro activities of several plant extracts against protozoan parasites are reported. The most active extracts were from M. parviflora, S. costus, C. wightii, J. pelargonifolia and S. villosum. Although P. atlantica is not the most active plant, it showed high selectivity toward all tested protozoa and no cytotoxicity. Yet all the active samples demonstrated nonspecific activity. Translation of some in vitro results into in vivo follow-up studies is recommended in the future. 
Future perspective
Natural antiprotozoal agents continue to be an important approach in exploring new treatments and result in controlling sleeping sickness, Chagas disease and leishmaniasis due to the rapid development of protozoan resistance to the synthetic drugs. The expansion of screening of medicinal plants for their antiprotozoal activity will greatly help in finding new agents with higher efficacy and better safety profile. These newly discovered potent antiprotozoal agents from medicinal plants in this study and other future studies could impact human medicine positively in the future as they demonstrated very promising activity and acceptable safety profile that may permit future progression to further trials for their evaluation in animals and human trials.
Summary points
• Trypanosomiasis and leishmaniasis are a major health problem worldwide.
• In vitro screening of the antiprotozoal activity of 31 medicinal plants was carried out.
• The plant extracts were tested against three Trypanosoma and one Leishmania species.
• The plant extracts were tested for their cytotoxicity against MRC-5.
• Maytenus parviflora showed the highest activity against Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
• Saussurea costus and Commiphora wightii, showed strong activity against Trypanosoma cruzi.
• Jatropha pelargonifolia and Solanum villosum exhibited strong activity toward Leishmania infantum.
• Solanum villosum showed the best selectivity index toward L. infantum.
